The Korean Journal of Helicobacter and Upper Gastrointestinal Research

[English]

Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study: Jin Lee, Jongha Park, Jino Park, Yong Eun Park, Joon Hyuk Choi, Nae-Yun Heo, Seung Ha Park, Tae Oh Kim; Korean J Helicobacter Up Gastrointest Res 2026;26(1):73-78. Published online January 20, 2026; DOI: https://doi.org/10.7704/kjhugr.2025.0065
Cited By 1; Full text PubReader ePub PDF

[English]

Evaluation of the Safety and Efficacy of K-CAB (Tegoprazan) as Symptomatic Maintenance Therapy in Patients With NERD: A Multicenter, Randomized Double-Blinded Controlled Trial: Yong Hwan Kwon, Joong Goo Kwon, June Hwa Bae, Hyeong Ho Jo, Eun Young Kim, Seong Woo Jeon, Yun Jin Chung, Ju Yup Lee, Kyung Sik Park, Si Hyung Lee, Chang Hun Yang, Daegu-Gyeongbuk Gastrointestinal Study Group; Korean J Helicobacter Up Gastrointest Res 2025;25(4):371-376. Published online December 4, 2025; DOI: https://doi.org/10.7704/kjhugr.2025.0054; Full text PubReader ePub PDF

[English]

Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Helicobacter pylori Eradication: Seokin Kang, Nam-Hoon Kim, Seokhyeon Jeong, Jong Wook Kim, Jung Rock Moon, Yoon Suk Lee, Jun Hyuk Son; Korean J Helicobacter Up Gastrointest Res 2024;24(2):168-174. Published online June 10, 2024; DOI: https://doi.org/10.7704/kjhugr.2024.0012
Cited By 4; Full text PubReader ePub PDF Supplementary Material

[Korean]

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs: Dong Han Yeom, Yong Sung Kim; Korean J Helicobacter Up Gastrointest Res 2023;23(3):159-166. Published online September 8, 2023; DOI: https://doi.org/10.7704/kjhugr.2023.0040
Cited By 6; Full text PubReader ePub PDF

Search